๐๐ฎ๐ฅ๐ฒ ๐๐๐ฐ๐ฌ ๐๐จ๐ฎ๐ง๐ ๐๐ฉ ๐ ๐๐๐ฎ๐ฌ๐๐ก & ๐๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฌ ๐๐ซ๐ฎ๐ค๐๐ซ๐...
๐๐๐ฎ๐ฌ๐๐ก & ๐๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฌ ๐๐ซ๐ฎ๐ค๐๐ซ๐ ๐๐๐๐ข๐๐๐ฅ: ๐๐ฑ๐ฉ๐๐ง๐๐ข๐ง๐ ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐๐ซ๐ฒ ๐๐ฒ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ
๐ค Bausch + Lomb recently announced its acquisition of Trukera Medical, a leader in ophthalmic medical diagnostics, through an affiliate. This strategic move introduces the innovative ScoutPro, a handheld and portable osmolarity system launched in October 2022. The ScoutPro, Trukeraโs first new product since rebranding, offers an all-in-one solution for tear osmolarity measurement, aiding in the diagnosis of dry eye disease (DED).
๐ As the only portable osmometer in the United States, the ScoutPro enhances the diagnostic process with its automated and quantitative capabilities. Bausch & Lomb refers to this acquisition as a "tuck-in" move, expected to bolster their surgical offerings and reinforce their leading position in the dry eye treatment market. The integration of ScoutProโs cutting-edge technology marks a significant step forward in Bausch & Lomb's commitment to advancing eye care.
